{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:10:54Z","timestamp":1773306654450,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1136\/ard.62.1.37","type":"journal-article","created":{"date-parts":[[2002,12,13]],"date-time":"2002-12-13T00:42:54Z","timestamp":1039740174000},"page":"37-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an Fc\u03b3RII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE"],"prefix":"10.1016","volume":"62","author":[{"given":"J","family":"R\u00f6nnelid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Tejde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Mathsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Nilsson-Ekdahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.62.1.37_bib1","first-page":"421","article-title":"Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus","volume":"4","author":"Llorente","year":"1993","journal-title":"Eur Cytokine Netw"},{"key":"10.1136\/ard.62.1.37_bib2","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/art.1780371114","article-title":"In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sj\u00f6gren\u2019s syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity","volume":"37","author":"Llorente","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.62.1.37_bib3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF02238963","article-title":"Interleukin-10 and interleukin-6 in lupus erythematosus and rheumatoid arthritis, correlations with acute phase proteins","volume":"16","author":"Lacki","year":"1997","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard.62.1.37_bib4","first-page":"281","article-title":"Circulating interleukin-6 type cytokines in patients with systemic lupus erythematosus","volume":"8","author":"Robak","year":"1997","journal-title":"Eur Cytokine Netw"},{"key":"10.1136\/ard.62.1.37_bib5","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1084\/jem.181.3.839","article-title":"Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus","volume":"181","author":"Llorente","year":"1995","journal-title":"J Exp Med"},{"key":"10.1136\/ard.62.1.37_bib6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF01541225","article-title":"Interleukin-10 (Il-10) secretion in systemic lupus erythematosus and rheumatoid arthritis - Il-10-dependent Cd4+Cd45ro+ T cell B cell antibody synthesis","volume":"16","author":"Aljanadi","year":"1996","journal-title":"J Clin Immunol"},{"key":"10.1136\/ard.62.1.37_bib7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/096120339500400510","article-title":"Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity","volume":"4","author":"Houssiau","year":"1995","journal-title":"Lupus"},{"key":"10.1136\/ard.62.1.37_bib8","first-page":"283","article-title":"Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus","volume":"16","author":"Park","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.62.1.37_bib9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/art.1780390305","article-title":"Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:interferon-gamma-secreting cells in the peripheral blood","volume":"39","author":"Hagiwara","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.62.1.37_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1365-2249.1999.00766.x","article-title":"Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE)","volume":"115","author":"Viallard","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.62.1.37_bib11","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.4049\/jimmunol.154.7.3454","article-title":"Regulatory effects of intrinsic IL-10 in IgG immune complex-induced lung injury","volume":"154","author":"Shanley","year":"1995","journal-title":"J Immunol"},{"key":"10.1136\/ard.62.1.37_bib12","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1172\/JCI117837","article-title":"Immune complexes inhibit antimicrobial responses through interleukin-10 production. Effects in severe combined immunodeficient mice during Listeria infection","volume":"95","author":"Tripp","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.62.1.37_bib13","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/eji.1830260618","article-title":"Immune complex-induced interleukin-6, interleukin-10 and prostaglandin secretion by human monocytes: a network of pro- and antiinflammatory cytokines dependent on the antigen-antibody ratio","volume":"26","author":"Berger","year":"1996","journal-title":"Eur J Immunol"},{"key":"10.1136\/ard.62.1.37_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0923-2516(96)80223-8","article-title":"Distinct antigen-induced cytokine pattern upon stimulation with antibody-complexed antigen consistent with a Th1\u2192Th2-shift","volume":"147","author":"Berger","year":"1996","journal-title":"Res Virol"},{"key":"10.1136\/ard.62.1.37_bib15","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1002\/eji.1830271136","article-title":"Immune complexes are potent inhibitors of interleukin-12 secretion by human monocytes","volume":"27","author":"Berger","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.1136\/ard.62.1.37_bib16","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"et al. The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.62.1.37_bib17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-3083.1994.tb03457.x","article-title":"Short-term kinetics of the humoral anti-C1q response in SLE using the ELISPOT method: fast decline in production in response to steroids","volume":"40","author":"R\u00f6nnelid","year":"1994","journal-title":"Scand J Immunol"},{"key":"10.1136\/ard.62.1.37_bib18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1084\/jem.134.3.228","article-title":"C1q precipitins in the sera of patients with systemic lupus erythematosus and other hypocomplementemic states: characterization of high and low molecular weight types","volume":"134","author":"Agnello","year":"1971","journal-title":"J Exp Med"},{"key":"10.1136\/ard.62.1.37_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0022-1759(84)90432-0","article-title":"Simplified assays of hemolytic activity of the classical and alternative pathways","volume":"72","author":"Nilsson","year":"1984","journal-title":"J Immunol Methods"},{"key":"10.1136\/ard.62.1.37_bib20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/ar71","article-title":"Cellular reactivity to collagen type II in rheumatoid arthritis is associated with HLADRB1*0401 and DQ8","volume":"2","author":"Berg","year":"2000","journal-title":"Arthritis Res"},{"key":"10.1136\/ard.62.1.37_bib21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0022-1759(96)00170-6","article-title":"A comparison between ELISPOT methods for the detection of cytokine producing cells: greater sensitivity and specificity using ELISA plates as compared to nitrocellulose membranes","volume":"200","author":"R\u00f6nnelid","year":"1997","journal-title":"J Immunol Methods"},{"key":"10.1136\/ard.62.1.37_bib22","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/1529-0131(199908)42:8<1649::AID-ANR13>3.0.CO;2-D","article-title":"Increased number of interleukin-10-producing cells in systemic lupus erythematosus patients and their first-degree relatives and spouses in Icelandic multicase families","volume":"42","author":"Gr\u00f6ndal","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.62.1.37_bib23","first-page":"565","article-title":"Cytokine production, serum levels and disease activity in systemic lupus erythematosus","volume":"18","author":"Gr\u00f6ndal","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.62.1.37_bib24","first-page":"259","article-title":"Direct comparison of ELISPOT and ELISA-based assays for detection of individual cytokine secreting cells","volume":"13","author":"Tanguay","year":"1994","journal-title":"Lymphokine Cytokine Res"},{"key":"10.1136\/ard.62.1.37_bib25","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF01541395","article-title":"Clinical, hematologic, and immunologic effects of interleukin-10 in humans","volume":"16","author":"Fuchs","year":"1996","journal-title":"J Clin Immunol"},{"key":"10.1136\/ard.62.1.37_bib26","first-page":"111","article-title":"Interleukin 10 inhibits interleukin 6 production and acute phase response in rheumatoid arthritis","volume":"43","author":"Lacki","year":"1995","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1136\/ard.62.1.37_bib27","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1046\/j.1365-3083.1997.d01-140.x","article-title":"Interleukin-10 response abnormalities in systemic lupus erythematosus","volume":"46","author":"Mongan","year":"1997","journal-title":"Scand J Immunol"},{"key":"10.1136\/ard.62.1.37_bib28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1006\/clim.1998.4680","article-title":"Exogenous IL-10 and IL-4 down-regulate IL-6 production by SLE-derived PBMC","volume":"91","author":"Linker-Israeli","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1136\/ard.62.1.37_bib29","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.4049\/jimmunol.151.12.6853","article-title":"Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis","volume":"151","author":"Wanidworanun","year":"1993","journal-title":"J Immunol"},{"key":"10.1136\/ard.62.1.37_bib30","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/107999002753675730","article-title":"Type I interferons inhibit interleukin-10 production in activated human monocytes and stimulate IL-10 in T-cells: implications for Th1-mediated diseases","volume":"22","author":"Feng","year":"2002","journal-title":"J Interferon Cytokine Res"},{"key":"10.1136\/ard.62.1.37_bib31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1471-4906(01)01955-X","article-title":"An etiopathogenic role for the type I IFN system in SLE","volume":"22","author":"R\u00f6nnblom","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1136\/ard.62.1.37_bib32","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1126\/science.1064890","article-title":"Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus","volume":"294","author":"Blanco","year":"2001","journal-title":"Science"},{"key":"10.1136\/ard.62.1.37_bib33","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s002510050426","article-title":"IgG receptor polymorphisms: risk factors for disease","volume":"48","author":"van der Pol","year":"1998","journal-title":"Immunogenetics"},{"key":"10.1136\/ard.62.1.37_bib34","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/1529-0131(199909)42:9<1828::AID-ANR6>3.0.CO;2-F","article-title":"Overrepresentation of the Fcgamma receptor type IIA R131\/R131 genotype in caucasoid systemic lupus erythematosus patients with autoantibodies to C1q and glomerulonephritis","volume":"42","author":"Norsworthy","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.62.1.37_bib35","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/1529-0131(199807)41:7<1181::AID-ART6>3.0.CO;2-C","article-title":"Fcgamma receptor IIa polymorphism in Caucasian patients with systemic lupus erythematosus: association with clinical symptoms","volume":"41","author":"Manger","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.62.1.37_bib36","first-page":"509","article-title":"FCgammaRII (CD32)-dependent induction of interferon-alpha by serum from patients with lupus erythematosus","volume":"10","author":"Batteux","year":"1999","journal-title":"Eur Cytokine Netw"},{"key":"10.1136\/ard.62.1.37_bib37","first-page":"909","article-title":"Precipitin reactions of the C1q component of complement with aggregated gamma-globulin and immune complexes in gel diffusion","volume":"19","author":"Agnello","year":"1970","journal-title":"Immunology"},{"key":"10.1136\/ard.62.1.37_bib38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1084\/jem.134.3.169","article-title":"Systemic lupus erythematosus: prototype of immune complex nephritis in man","volume":"134","author":"Koffler","year":"1971","journal-title":"J Exp Med"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724091337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724091337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.62.1.37","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T23:37:30Z","timestamp":1737243450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724091337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["S0003496724091337"],"URL":"https:\/\/doi.org\/10.1136\/ard.62.1.37","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2003,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an Fc\u03b3RII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.62.1.37","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Copyright 2003 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}